DNA Diagnostics Market is Expected to Reach $19 Billion
"Next generation sequencing not only reduces the cost of sequencing, but increases the throughput as well; it could thus help in bridging the gaps in traditional and personalized medications", adds the analyst. This makes it a promising investment opportunity for key players. Illumina Inc.'s new cost-effective genome machine HiSeq X Ten -the world's first DNA crunching supercomputer- is leading to a significant reduction in the price of sequencing a human genome. Download the Sample Report @ http://bit.ly/2xgU10S DNA diagnostics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $19 billion by 2020, registering a CAGR of 9.8% during the period 2014-2020. The potential to provide accurate diagnosis and cost effectiveness over alternative diagnostic techniques are factors which supplement the growth of the DNA diagnostics market. AMR analysis suggests that the tremendous potential of novel DNA diagnostic ...